149 related articles for article (PubMed ID: 9883009)
1. Differences in the management of inflammatory bowel disease in children and adolescents compared to adults.
Kirschner BS
Neth J Med; 1998 Dec; 53(6):S13-8. PubMed ID: 9883009
[TBL] [Abstract][Full Text] [Related]
2. Current therapy of inflammatory bowel disease in children.
Rufo PA; Bousvaros A
Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
[TBL] [Abstract][Full Text] [Related]
3. Problems in diagnosis of IBD in children.
Büller HA
Neth J Med; 1997 Feb; 50(2):S8-11. PubMed ID: 9050326
[TBL] [Abstract][Full Text] [Related]
4. Treatment of inflammatory bowel disease in the adolescent.
Rayhorn N
J Infus Nurs; 2001; 24(4):255-62. PubMed ID: 11507789
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy of inflammatory bowel disease for the 21st century.
Robinson M
Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease: symptoms in the bowel and beyond.
Rayhorn N; Rayhorn DJ
Nurse Pract; 2002 Nov; 27(11):13-27; quiz, 28-9. PubMed ID: 12444363
[TBL] [Abstract][Full Text] [Related]
7. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
10. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB; Stathopoulos G
Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the management of growth failure in childhood inflammatory bowel disease.
Heuschkel R; Salvestrini C; Beattie RM; Hildebrand H; Walters T; Griffiths A
Inflamm Bowel Dis; 2008 Jun; 14(6):839-49. PubMed ID: 18266237
[TBL] [Abstract][Full Text] [Related]
12. Conventional treatment of Crohn's disease: objectives and outcomes.
Rutgeerts PJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
[TBL] [Abstract][Full Text] [Related]
14. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
15. [Chronic inflammatory bowel diseases and nutrition].
Meier R
Schweiz Med Wochenschr Suppl; 1996; 79():14S-24S. PubMed ID: 8701255
[TBL] [Abstract][Full Text] [Related]
16. Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD.
Markowitz J; Daum F; Cohen SA; Glassman M; Holmes RD; Piccoli D; Rossi TM; Treem WR; Ulshen MH; Winter HS
J Pediatr Gastroenterol Nutr; 1991 May; 12(4):411-23. PubMed ID: 1678006
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy of inflammatory bowel disease.
Sack DM; Peppercorn MA
Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
[TBL] [Abstract][Full Text] [Related]
18. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
19. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
20. Advances in inflammatory bowel diseases in children.
Michail S; Ramsy M; Soliman E
Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
